Investment Summary

Dai-ichi Life Invests In Instalimb

On March 6, 2024, Dai-ichi Life invested in medical products company Instalimb

Investment Highlights
  • This is Dai-ichi Life’s 1st transaction in the Medical Products sector.
  • This is Dai-ichi Life’s 1st transaction in Japan.

Investment Summary

Date 2024-03-06
Target Instalimb
Sector Medical Products
Investor(s) Dai-ichi Life
Deal Type Growth Capital

Target

Instalimb

Tokyo, Japan
website
Instalimb provides 3D-printed prosthetic legs by introducing 3D printing and machine-learning technologies. Instalimb is based in Tokyo, Japan.

Search 192,907 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

Dai-ichi Life

Tokyo, Japan

website


Category Company
Founded 1902
Sector Insurance
Employees62,260
Revenue 7,858.1B JPY (2022)
DESCRIPTION

Dai-ichi Life is a life insurance company. Dai-ichi offers underwriting of insurance policies, including personal insurance, individual annuity insurance, group insurance, group pension insurance, other insurances and reinsurance. Dai-ichi Life was founded in 1902 and is based in Tokyo, Japan.


DEAL STATS #
Overall 3 of 4
Sector (Medical Products) 1 of 1
Type (Growth Capital) 1 of 1
Country (Japan) 1 of 1
Year (2024) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-08-12 Partners Life

Auckland, New Zealand

Partners Life is a provider of life insurance, income protection, medical insurance, disability insurance, trauma cover and business risk protection products and services. Partners Life was formed in 2010 and is based in Auckland, New Zealand.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2024-03-07 Rakuten Medical

San Diego, California, United States

Rakuten Medical is a global biotechnology company developing precision, cell-targeting investigational therapies on its IlluminoxTM platform, which, in preclinical studies have shown to lead to rapid and selective cell killing and tumor necrosis. Illuminox therapies have not yet been approved by any regulatory authority. Rakuten Medical was formed in 2010 and is based in San Diego, California.

Buy -